BRD4 Antibodies

Santa Cruz Biotechnology delivers a wide array of BRD4 monoclonal antibodies for various research applications. BRD4 monoclonal antibodies are recommended for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BRD4, a member of the bromodomain and extraterminal (BET) family of proteins, plays a crucial role in regulating gene expression and is involved in various cellular processes, including transcriptional regulation and chromatin remodeling. BRD4's importance is highlighted by its association with several cancers and inflammatory diseases, making it a significant target for therapeutic intervention. Researchers worldwide utilize BRD4 monoclonal antibodies to investigate cellular pathways and molecular mechanisms. Characterization of BRD4 has revealed its vital functions in cell cycle progression and transcriptional elongation. Understanding BRD4's role in normal cellular functions provides insights into disease development and potential treatment strategies. BRD4 monoclonal antibodies from Santa Cruz Biotechnology enable researchers to advance scientific knowledge and contribute to the development of targeted therapies.